PTGX
Protagonist Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -6.7% ·
Aktienfluss +2.2% ·
neue Nettopositionen -7.1%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +1 | 45.41M | $5.57B | +7 | −6 |
| Q1 2026 | 108 | -1 | 49.99M | $5.27B | +9 | −10 |
| Q4 2025 | 107 | +4 | 45.87M | $4.01B | +4 | — |
| Q3 2025 | 17 | 0 | 26.31M | $1.75B | +2 | −2 |
| Q2 2025 | 14 | -1 | 22.53M | $1.25B | +1 | −2 |
| Q1 2025 | 12 | +1 | 7.51M | $363.26M | +3 | −2 |
| Q4 2024 | 11 | -2 | 7.82M | $302.00M | — | −2 |
| Q3 2024 | 12 | +2 | 4.92M | $221.52M | +3 | −1 |
| Q2 2024 | 10 | — | 7.44M | $257.83M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 9.63M | — | $532.27M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passiv) | 4.36M | — | $240.90M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passiv) | 4.36M | — | $240.90M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passiv) | 4.36M | — | $240.90M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passiv) | 4.36M | — | $240.90M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passiv) | 4.36M | — | $240.90M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (passiv) | 3.21M | +18.5% | $177.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passiv) | 1.44M | +1.4% | $79.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passiv) | 1.44M | +1.4% | $79.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 1.09M | +218.0% | $60.37M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 32 | Wellington Management ✦ | 1.04M | +5.1% | $57.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 936.70K | -29.1% | $51.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 936.70K | -29.1% | $51.77M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 538.43K | — | $29.76M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 538.43K | — | $29.76M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 173.13K | -46.5% | $9.57M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 37.29K | +61.6% | $2.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 27.20K | -82.3% | $1.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Arrowstreet Capital ✦ | 17.86K | Neu | $986,901 | 0.0% | New | 1 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 17.41K | -56.6% | $962,195 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 17.41K | -56.6% | $962,195 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 17.41K | -56.6% | $962,195 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 17.41K | -56.6% | $962,195 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 45 | Millennium Management ✦ | 15.19K | -88.7% | $839,607 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Arrowstreet Capital | $986,901 | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $2.29M | war 0.0% |
| Two Sigma Investments | $277,635 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 5.04K Anteile, $530,799 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 34.24K Ant. · $5.09M
Officer, Director · 65.76K Ant. · $9.81M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik